AboutIsomerase Therapeutics
Who we are
Isomerase Therapeutics was founded in 2012 and is a privately-held drug discovery and development services company based near Cambridge, UK.
We are an established and successful research partner for companies looking to accelerate their discovery and development in the health and life-sciences sectors. Our outstanding commercial success was recognised in 2017 by a prestigious Queen's Award for Enterprise.
We operate a bespoke biosynthetic engineering and semisynthetic chemistry platform that can rapidly move your chosen microbial product from interesting hit to high value candidate drug or commercially attractive product. We are also experienced at using strain and process improvement, synthetic biology, fermentation, analytical and isolation chemistry to support microbial products from concept to commercially valuable projects.
We offer our services in a flexible collaborative model to partners seeking more than just a CRO.
At the forefront of natural product bioengineering
We combine leading-edge synthetic biology, advanced strain bioengineering and biosynthetic medicinal chemistry approaches to discover new leads and rapidly optimise these into highly valuable drug candidates and commercial products.
Syn Bio Bioengineering
At the forefront of natural product bioengineering
Natural products remain one of the most important routes to new drugs and commercially attractive products
Exploiting the power of microbial natural products
Synthetic Biology
Recent advances in the ability to read/write and assemble DNA provide a powerful tool to manipulate microbial metabolism. We offer an extensive synthetic biology toolkit to enhance and accelerate your R&D
Chemistry
The combination of chemistry and biology frequently delivers new insight and opportunity. It also allows us to maximise the value we create for partners. We have considerable expertise in understanding how to interrogate and augment microbial processes with effective and scalable chemistry.
Strain Bioengineering
We are in an era of unprecedented ability to engineer microbes to enable completely novel bioprocesses or to improve and optimise existing ones. Our deep understanding & experience enables the design of novel patentable strains and processes.
Fermentation
The ability to grow microbes in a controlled environment is an essential capability in bioprocessing. We operate from small high throughput systems through bench-scale and small pilot bioreactors to large-scale manufacturing.
